SG11201903443QA - Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles - Google Patents

Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles

Info

Publication number
SG11201903443QA
SG11201903443QA SG11201903443QA SG11201903443QA SG11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA SG 11201903443Q A SG11201903443Q A SG 11201903443QA
Authority
SG
Singapore
Prior art keywords
composite particles
peptide
polymer
anionic polymer
cationic polymer
Prior art date
Application number
SG11201903443QA
Other languages
English (en)
Inventor
Ryota Hayashi
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2016203809A external-priority patent/JP6901841B2/ja
Priority claimed from JP2016204693A external-priority patent/JP6956478B2/ja
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of SG11201903443QA publication Critical patent/SG11201903443QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0283—Matrix particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mathematical Physics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Manufacturing & Machinery (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Cosmetics (AREA)
SG11201903443QA 2016-10-17 2017-10-04 Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles SG11201903443QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016203809A JP6901841B2 (ja) 2016-10-17 2016-10-17 アニオン性ポリマー及びペプチドを含む複合粒子及びその製造方法
JP2016204693A JP6956478B2 (ja) 2016-10-18 2016-10-18 アニオン性ポリマー及びカチオン性ポリマーを含む複合粒子
PCT/JP2017/036146 WO2018074237A1 (fr) 2016-10-17 2017-10-04 Particules composites comprenant un polymère anionique et un polymère ou peptide cationique, et procédé de production de particules composites

Publications (1)

Publication Number Publication Date
SG11201903443QA true SG11201903443QA (en) 2019-05-30

Family

ID=62019641

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201903443QA SG11201903443QA (en) 2016-10-17 2017-10-04 Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles

Country Status (8)

Country Link
US (2) US11707419B2 (fr)
EP (2) EP3799858A1 (fr)
KR (3) KR102301452B1 (fr)
CN (3) CN115192468B (fr)
MY (1) MY192816A (fr)
SG (1) SG11201903443QA (fr)
TW (1) TWI784978B (fr)
WO (1) WO2018074237A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201903443QA (en) * 2016-10-17 2019-05-30 Pola Chem Ind Inc Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles
KR102099842B1 (ko) * 2019-09-26 2020-04-10 (주)리젠바이오참 조직재생용 하이드로겔 조성물 및 이를 이용하여 제조된 지지체
JP2021095361A (ja) * 2019-12-17 2021-06-24 ロレアル ヒアルロン酸系ポリイオンコンプレックス粒子を含む組成物
WO2021171206A1 (fr) * 2020-02-24 2021-09-02 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Procédés d'amélioration de l'administration transdermique de glycosaminoglycanes (gags)
CN112063221B (zh) * 2020-09-18 2022-11-15 山东华熙海御生物医药有限公司 含透明质酸的着色助剂、制法及其应用
FR3118700A1 (fr) * 2021-01-13 2022-07-15 L'oreal Composition comprenant une particule de complexe polyionique et une charge
EP4259067A1 (fr) * 2020-12-14 2023-10-18 L'oreal Composition comprenant une particule complexe de polyion et une charge
CN114699335B (zh) * 2022-04-25 2023-11-03 广州创尔生物技术股份有限公司 一种稳定的胶原蛋白-透明质酸互溶体系及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056338B2 (en) * 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
ES2226567B1 (es) 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
JP4461727B2 (ja) * 2003-07-18 2010-05-12 チッソ株式会社 外用剤組成物
US20050196343A1 (en) * 2004-02-27 2005-09-08 Molecular Therapeutics, Inc. Degradable nanoparticles
ES2259914B1 (es) 2005-03-14 2007-06-16 Advanced In Vitro Cell Technologies, S.L. Nanoparticulas de quitosano y polietilenglicol como sistema de administracion de moleculas biologicamente activas.
JP2009514860A (ja) * 2005-11-02 2009-04-09 エアリス セラピューティクス，インコーポレイテッド ポリカチオン−ポリアニオンの複合体、組成物およびその使用方法
CN101448939B (zh) 2006-05-17 2011-12-14 小山义之 用于导入核酸、寡核酸或其衍生物的冷冻干燥体
JP2009537604A (ja) 2006-05-24 2009-10-29 アドヴァンスド イン ヴィトロ セル テクノロジーズ ソシエダッド アノニマ 活性分子の投与のためのキトサンおよびヒアルロナンのナノ粒子
EP2166022B1 (fr) * 2007-04-24 2016-09-21 Q.P. Corporation Acide hyaluronique cationisé et/ou sel de celui-ci, procédé de fabrication de ceux-ci, et agent modificateur capillaire, agent de réparation des cuticules, agent de modification de la peau et préparation cosmétique utilisant chacun ceux-ci
JP5085976B2 (ja) * 2007-05-09 2012-11-28 株式会社 資生堂 球状複合ゲル粒子の製造方法
JP2010540411A (ja) 2007-05-11 2010-12-24 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ ネブラスカ タンパク質送達のための組成物およびその使用方法
WO2009079066A2 (fr) * 2007-09-26 2009-06-25 Aparna Biosciences Produit thérapeutique et compositions de nanoparticules de polyélectrolyte de vaccin
US8093365B2 (en) * 2008-03-03 2012-01-10 New York University Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same
EP2172193A1 (fr) * 2008-10-02 2010-04-07 Capsulution Nanoscience AG Compositions de nanoparticules améliorées de composés faiblement solubles
WO2010049562A1 (fr) * 2008-10-28 2010-05-06 Universidade De Santiago De Compostela Systèmes nanoparticulaires élaborés à base de polymères anioniques
JP5835741B2 (ja) * 2010-02-26 2015-12-24 国立大学法人 長崎大学 抗原または薬物送達複合体
CN102210871A (zh) * 2010-07-16 2011-10-12 钟术光 缓释释药的药物载体
JP6292655B2 (ja) 2012-10-11 2018-03-14 ポーラ化成工業株式会社 キトサン及びヒアルロナンを含むナノ粒子
JP6162943B2 (ja) * 2012-11-02 2017-07-12 ポーラ化成工業株式会社 ヒアルロナンを含むナノ粒子
US10202517B2 (en) * 2013-07-26 2019-02-12 The Penn State Research Foundation Polymer compositions and coatings
JP6444310B2 (ja) 2013-10-28 2018-12-26 テルモ株式会社 モノクローナル抗体の安定化方法
WO2015189387A1 (fr) 2014-06-13 2015-12-17 Sanofi Formulation nanocapsulaire d'ingrédients pharmaceutiques actifs
JP6602626B2 (ja) 2015-09-28 2019-11-06 嘉寛 徳留 ヒアルロナンを含む複合粒子を含有する乳化組成物
CN105726511A (zh) * 2016-03-10 2016-07-06 温州医科大学 一种自发组装的多聚赖氨酸接枝物纳米粒及其制备与应用
SG11201903443QA (en) * 2016-10-17 2019-05-30 Pola Chem Ind Inc Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles

Also Published As

Publication number Publication date
TW201828916A (zh) 2018-08-16
KR20200122431A (ko) 2020-10-27
US11707419B2 (en) 2023-07-25
CN113995731A (zh) 2022-02-01
EP3799858A1 (fr) 2021-04-07
EP3527194C0 (fr) 2024-02-14
EP3527194A1 (fr) 2019-08-21
TWI784978B (zh) 2022-12-01
US20200289380A1 (en) 2020-09-17
KR20190059303A (ko) 2019-05-30
CN109862876A (zh) 2019-06-07
KR20200123274A (ko) 2020-10-28
US20190231655A1 (en) 2019-08-01
EP3527194A4 (fr) 2020-08-19
WO2018074237A1 (fr) 2018-04-26
CN109862876B (zh) 2022-07-22
KR102301452B1 (ko) 2021-09-10
EP3527194B1 (fr) 2024-02-14
CN115192468A (zh) 2022-10-18
MY192816A (en) 2022-09-09
KR102301456B1 (ko) 2021-09-10
KR102215375B1 (ko) 2021-02-15
CN115192468B (zh) 2024-02-13

Similar Documents

Publication Publication Date Title
SG11201903443QA (en) Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles
EP3640265A4 (fr) Fines fibres de cellulose, leur procédé de production, bouillie et composite
WO2016196315A3 (fr) Méthodes et systèmes de culture cellulaire
MX2016003740A (es) Particulas de dioxido de titanio y un proceso para su produccion.
MX369409B (es) Método para la fabricación de un producto perfilado de ácido hialurónico.
EP3774013A4 (fr) Aérogels hybrides contenant de la cellulose, xérogels hybrides, et procédé de production associé
LT2014048A (lt) Modifikuoto krakmolo flokuliantas ir jo gamybos būdas
MX2017010882A (es) Un producto de concreto fotocatalitico y un metodo para generar un producto de concreto fotocatalitico.
MY178048A (en) Coated titanium dioxide dispersions
EP3590970A4 (fr) Cellulose fibreuse, composition contenant de la cellulose fibreuse, dispersion liquide de cellulose fibreuse, et procédé de production de cellulose fibreuse
WO2019023057A3 (fr) Traitement de résidus miniers ou stériles de phosphates
PH12020500328A1 (en) Microorganism for producing a mycosporine-like amino acid and method for producing a mycosporine-like amino acid using the same
MX2011007731A (es) Pigmentos formadores de pelicula y sistema de recubrimiento que incluye los mismos.
BR112017022398A2 (pt) processo para produzir uma pasta fluida aquosa, pasta fluida aquosa, mescla de partículas, uso da mescla de partículas, e, papel, papel de seda, papel fotográfico digital, tintas, revestimentos, adesivos, plásticos ou agente de tratamento de águas residuais
EP3680290A4 (fr) Dispersion liquide de nanofibres de cellulose, résine composite à base de nanofibres de cellulose, et procédés de production de la dispersion et de la résine
MX2019008977A (es) Tratamiento de composiciones acuosas que incluyen finos.
BR112018076542A2 (pt) método para preparar partículas contendo celulose
WO2009041275A1 (fr) Procédé pour la production d'une dispersion microparticulaire aqueuse de résine, dispersion de ce type et microparticule de résine obtenues au moyen de ce procédé
EP3640283A4 (fr) Procédé de fabrication de particules de résine
WO2019018370A3 (fr) Traitement de résidus de sables bitumineux
AU2018253648A1 (en) Process for producing low endotoxin chitosan
MY181153A (en) Polymer, polymer modified titanium dioxide pigment, and method of forming a pigmented paint formulation
AU2012371722A8 (en) Method of making a polymer article and resulting article
WO2018110846A3 (fr) Procédé de préparation de graphène fonctionnalisé
MX2018004054A (es) Redispersion de esquizofilan.